<- Go Home
Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Market Cap
$25.5M
Volume
57.9K
Cash and Equivalents
$1.2M
EBITDA
-$8.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$74.0K
Profit Margin
100.00%
52 Week High
$9.00
52 Week Low
$2.74
Dividend
N/A
Price / Book Value
9.16
Price / Earnings
-12.83
Price / Tangible Book Value
15.25
Enterprise Value
$24.3M
Enterprise Value / EBITDA
-2.97
Operating Income
-$8.2M
Return on Equity
832.21%
Return on Assets
-162.14
Cash and Short Term Investments
$1.2M
Debt
N/A
Equity
$2.8M
Revenue
$74.0K
Unlevered FCF
-$3.8M
Sector
Health Care Technology
Category
N/A